Victor Eduardo Mulanovich, M.D.
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1990 | Universidad Peruana Cayetano Heredia, Lima, PE, Médico Cirujano |
Postgraduate Training
| 2007-2008 | Clinical Safety and Effectiveness Education Program, MD Anderson Cancer Center, Houston, Texas |
| 1994-1994 | CDC and AHA Training Course in Hospital Epidemiology, Society for Hospital Epidemiology of America, N/A |
| 1993-1995 | Fellowship, Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama |
| 1991-1993 | Residency, Internal Medicine, Henry Ford Hospital, Detroit, Michigan |
| 1990-1991 | Internship, Internal Medicine, Henry Ford Hospital, Detroit, Michigan |
Licenses & Certifications
| 2024 | Washington State Department of Health |
| 2023 | Georgia Composite Medical Board |
| 2023 | Tennessee Board of Medical Examiners |
| 2023 | Oklahoma State Board of Medical Licensure |
| 2023 | Mississippi State Board of Medical Licensure |
| 2023 | Arizona Board of Medical Examiners |
| 2023 | Louisiana State Board of Medical Examiners |
| 2017 | American Board of Medical Quality |
| 2005 | Texas Medical Board |
| 1996 | American Board of Internal Medicine, Sub-specialty certification in Infectious Diseases |
| 1995 | Florida Board of Medicine |
| 1993 | American Board of Internal Medicine |
| 1993 | Alabama Board of Medical Examiners |
Experience & Service
Faculty Academic Appointments
Adjunct Professor, Infectious Diseases, Baylor College of Medicine, Houston, TX, 2020 - 2023
Adjunct Associate Professor, Infectious Diseases, Baylor College of Medicine, Houston, TX, 2011 - 2020
Associate Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2015
Assistant Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2010
Assistant Professor, Infectious Diseases, The University of Texas Medical Branch, Galveston, TX, 2005 - 2006
Administrative Appointments/Responsibilities
Department Chair ad interim, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023
Administrative Director of the Antibiotic Stewardship Program, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Deputy Department Chair, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2021
Director of the Advanced Practice Providers Program, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2021
Extramural Institutional Committee Activities
Elected divisional representative, PRS Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Community of Chairs, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, Division of Internal Medicine Executive Council, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, Steering Committee for Stem Cell Transplantation and Cellular Therapy, Infectious Diseases and Collaborators, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, COVID-19 Response various committees and task forces, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Ashley, PA, Strati, P, Taherian, M, Mulanovich, VE, Ariza Heredia, E. Whipple's disease in a patient with follicular lymphoma. Diagnostic Microbiology and Infectious Disease 112(2), 2025. e-Pub 2025. PMID: 40043335.
- Long, JP, Prakash, R, Edelkamp, P, Knafl, M, Lionel, AC, Nair, R, Ahmed, S, Strati, P, Malpica Castillo, LE, Al Zaki, A, Chien, KS, Chihara, D, Westin, JR, Khawaja, F, Nastoupil, L, Mulanovich, VE, Futreal, A, Woodman, SE, Daver, N, Flowers, CR, Neelapu, SS, Manzano, JM, Iyer, SP. Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy. JAMA Network Open 8(4), 2025. e-Pub 2025. PMID: 40193078.
- Batista, MV, Sassine, J, Khawaja, F, Kulkarni, PA, Angelidakis, G, Kmeid, J, El Chaer, F, Ariza Heredia, E, Graviss, EA, Mulanovich, VE, Chemaly, RF. The Utility of Interferon-γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transplant Infectious Disease 27(2), 2025. e-Pub 2025. PMID: 39731624.
- Daher, M, Khawaja, F, Spallone, A, Shigle, TL, Bhatti, MM, Vuong, NN, Ariza Heredia, E, Mulanovich, VE, Champlin, RE, Chemaly, RF. Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transplant Infectious Disease 27(2), 2025. e-Pub 2025. PMID: 39826146.
- Khawaja, F, Ahmed, S, Iyer, S, Sassine, J, Handley, G, Prakash, R, Vanwierren, T, Jackson, J, Zubovskaia, A, Ramdial, JL, Rondon, G, Patel, K, Spallone, A, Ariza Heredia, E, Mulanovich, VE, Angelidakis, G, Jiang, Y, Chemaly, RF. Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy. Open Forum Infectious Diseases 11(8), 2024. e-Pub 2024. PMID: 39086466.
- Tverdek, FP, Aitken, SL, Mulanovich VE, Adachi, JA, Wu, C, Cantu, S, McDaneld, PM, Chemaly, RF. Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infectious Diseases 11(5), 2024. e-Pub 2024. PMID: 38798895.
- Franklin A, John TM, Khawaja F, Jiang Y, Yepez E, Ahuja J, Faiz SA, Bashoura L, Sheshadri A, Shannon VR, Balachandran DD, McConn K, Effort Team DDFCOD, Mulanovich VE, Bhatti M, Chemaly RF. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis 228(11):1549-1558, 2023. e-Pub 2023. PMID: 37983000.
- Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Fernández Cruz A, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich VE, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (DCODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife 12, 2023. e-Pub 2023. PMID: 36715684.
- Dagher H, Chaftari AM, Mulanovich VE, Jiang Y, Hachem R, Malek AE, Borjan J, Viola GM, Raad I. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. Elife 11, 2022. e-Pub 2022. PMID: 36541589.
- Chaftari AM, Hachem R, Malek AE, Mulanovich VE, Szvalb AD, Jiang Y, Yuan Y, Ali S, Deeba R, Chaftari P, Raad I. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis 9(6):ofac079, 2022. e-Pub 2022. PMID: 35663286.
- Angelidakis G, Khawaja F, Mulanovich VE, Dailey-Garnes N, Ariza-Heredia E, Chemaly RF. Combination of Baloxavir and Oseltamivir for Treatment of Severe Influenza Infection in Hematopoietic Cell Transplant Recipients: A Novel Treatment Strategy for a High-risk Population. Microbes Infect 24(3):104895, 2022. e-Pub 2022. PMID: 34756990.
- Chaftari P, Chaftari AM, Hachem R, Yeung SJ, Dagher H, Jiang Y, Malek AE, Dailey Garnes N, Mulanovich VE, Raad I. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med 10(23):8475-8482, 2021. e-Pub 2021. PMID: 34725958.
- Malek A, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich VE, Viola G, Raad I. Impact of Checkpoint Inhibitor Immunotherapy Primarily Pembrolizumab on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis 73(9):e2697-e2704, 2021. e-Pub 2021. PMID: 32564081.
- Handley G, Khawaja F, Kondapi DS, Lee HJ, Kaufman GP, Neelapu SS, Fayad LE, Tummala S, Chi L, Strati P, Mulanovich VE. Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. Int J Infect Dis 112:327-329, 2021. e-Pub 2021. PMID: 34600133.
- Strati P, Varma A, Adkins S, Nastoupil LJ, Westin J, Hagemeister FB, Fowler NH, Lee HJ, Fayad LE, Samaniego F, Ahmed S, Chen Y, Horowitz S, Arafat S, Johncy S, Kebriaei P, Mulanovich VE, Ariza Heredia E, Neelapu SS. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica 106(10):2667-2672, 2021. e-Pub 2021. PMID: 32732355.
- Mori N, Szvalb AD, Adachi JA, Tarrand JJ, Mulanovich VE. Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer. BMC Infect Dis 21(1):1021, 2021. e-Pub 2021. PMID: 34587893.
- Malek AE, Adachi JA, Mulanovich VE, Sassine J, Raad II, McConn K, Seiler GT, Dhal U, Khawaja F, Chemaly RF. Immune Reconstitution and Severity of COVID-19 among Hematopoietic Cell Transplant Recipients. Transpl Infect Dis 23(4):e13606, 2021. e-Pub 2021. PMID: 33755273.
- Olson A, Lin R, Marin D, Rafei H, Bdaiwi MH, Thall PF, Basar R, Abudayyeh A, Banerjee P, Aung FM, Kaur I, Abueg G, Rao S, Chemaly R, Mulanovich VE, Al-Atrash G, Alousi AM, Andersson BS, Anderlini P, Bashir Q, Castro KM, Daher M, Galvan IM, Hosing C, Im JS, Jones RB, Kebriaei P, Khouri I, Mehta R, Molldrem J, Nieto Y, Oran B, Popat U, Qazilbash M, Rondon G, Saini N, Spencer B, Srour S, Washington D, Barnett M, Champlin RE, Shpall EJ, Rezvani K. Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. J Clin Oncol 39(24):2710-2719, 2021. e-Pub 2021. PMID: 33929874.
- Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich VE, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front Immunol 12:675679, 2021. e-Pub 2021. PMID: 33995420.
- Malek AE, Skaff Y, Mulanovich VE. Voriconazole-induced periostitis in stem cell transplant patient. Infection, 2020. e-Pub 2020. PMID: 32430648.
Invited Articles
- Holloway S, McConn K, Borchardt R, Mulanovich VE, Adachi JA. Mitigating Burnout: Transition to a Condensed Workweek for Advanced Practice Providers in Infectious Diseases. J Adv Pract Oncol 14(7):639-643, 2023. e-Pub 2023. PMID: 38196670.
Other Articles
- Malek AE, Skaff Y, Mulanovich VE Correction to: Voriconazole-induced periostitis in stem cell transplant patient. Infection 48(5):811, 2020. PMID: 32562086.
Abstracts
- Lionel A, Long J, Prakash R, Jr PE, Kna M, Ahmed S, Strati P, Nair R, Chien KS, Chihara D, Westin J, Khawaja F, Nastoupil LJ, Manzano J, Mulanovich VE, Daver N, Futreal A, Woodman SE, Flowers CR, Neelapu SS, Iyer SP. Differing Inflammatory Profiles and Survival Outcomes of Cytokine Storm Arising from CAR T-Cell Therapy, COVID and Malignancy-Associated HLH in Patients with Hematological Malignancies. 65th American Society of Hematology annual meeting 142(Supplement 1):3507, 2023. e-Pub 2023.
- Prakash R, Long J, Jr PE, Knafl M, Ahmed S, Khawaja F, Nastoupil LJ, Manzano J, Mulanovich VE, Prabhakaran S, Futreal A, Woodman SE, Iyer SP. Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections. 64th American Society of Hematology Meeting 140(Supplement 1):10907-10908, 2022. e-Pub 2022.
- Al-Juhaishi T, Malek AE, Denái RM, Ramdia JL, Daher M, Olson AL, Srour SA, Alatrash G, Oran B, Mehta RS, Khouri IF, Bashir Q, Shah N, Ciurea SO, Rondon G, Maadani F, Hosing C, Marin D, Kebriaei P, Rezvani K, Nieto N, Anderlini P, Alousi AM, Qazilbash MH, Popat UR, Champlin RE, Shpall EJ, Mulanovich VE, Ahmed S. Incidence and Outcomes of Toxoplasma Reactivation in Patients with Hematologic Diseases after Allogeneic Hematopoietic Stem Cell Transplantation. 63rd American Society of Hematology Annual Meeting 138(Supplement 1):1779-1781, 2021. e-Pub 2021.
- Malek A, Chaftari P, Okhuysen P, Dagher, Torres H, Hachem R, Chaftari A, Viola G, Kontoyiannis D, Mulanovich V, Raad I. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy. Open Forum Infectious Diseases 8(Supplement 1):S789, 2021. e-Pub 2021.
- Dagher H, Chaftari A, Hachem R, Jiang Y, Malek A, Garnes N, Borjan J, Mulanovich VE, Raad I. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19. Open Forum Infectious Diseases 8(Supplement 1):S282, 2021. e-Pub 2021.
Book Chapters
- Yepez Guevara E, Rahman RA, Daher M, Mulanovich VE. Management of infections in stem cell transplant recipients. In: Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Elsevier, Inc, 429-442, 2024.
Letters to the Editor
- Malek, A, Al-Juhaishi, T, Milton, D, Ramdial, JL, Daher, M, Olson, AL, Srour, S, Al-Atrash, G, Oran, B, Mehta, RS, Khouri, IF, Bashir, Q, Shah, N, Ciurea, SO, Rondon, G, Maadani, F, Hosing, C, Marin, D, Kebriaei, P, Rezvani, K, Nieto, Y, Anderlini, P, Alousi, AM, Faisal, MS, Qazilbash, MH, Popat, UR, Champlin, RE, Shpall, E, Mulanovich VE, Ahmed, S. Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis. Bone marrow transplantation 59: 699-704, 2024.
- Manasanch EE, Mulanovich VE, Manzano JG, Gaeta MS, Becnel M, Kaufman GP, Lee HC, Amini B, Thomas SK, Iyer SP, Weber DM, Berkova Z, Flowers CR, Orlowski RZ, Patel KK. SARS-CoV-2 in multiple myeloma: initial observation and management. Leuk Lymphoma 61: 2763-2766, 2020.
- John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95: 2038-2040, 2020.
Patient Reviews
CV information above last modified August 04, 2026